https://stock.noler.com/us/stock/response-biomedical-corp https://stock.noler.com/us/stock/response-biomedical-corp/accounts-payable https://stock.noler.com/us/stock/response-biomedical-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/response-biomedical-corp/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/accounts-payable-trade-current https://stock.noler.com/us/stock/response-biomedical-corp/accounts-payable-trade-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/accounts-receivable https://stock.noler.com/us/stock/response-biomedical-corp/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/accrued-royalties-current https://stock.noler.com/us/stock/response-biomedical-corp/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/accumulated-depreciation https://stock.noler.com/us/stock/response-biomedical-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/response-biomedical-corp/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/response-biomedical-corp/additional-paid-in-capital https://stock.noler.com/us/stock/response-biomedical-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/response-biomedical-corp/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/response-biomedical-corp/allowance-for-doubtful-accounts-receivable-charge-offs https://stock.noler.com/us/stock/response-biomedical-corp/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/response-biomedical-corp/amended-reports-10-k https://stock.noler.com/us/stock/response-biomedical-corp/amended-reports-10-q https://stock.noler.com/us/stock/response-biomedical-corp/amended-reports-20-f https://stock.noler.com/us/stock/response-biomedical-corp/amortization https://stock.noler.com/us/stock/response-biomedical-corp/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/response-biomedical-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/response-biomedical-corp/basic-shares https://stock.noler.com/us/stock/response-biomedical-corp/cash-and-equivalents https://stock.noler.com/us/stock/response-biomedical-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/response-biomedical-corp/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/response-biomedical-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/response-biomedical-corp/clinical-trials https://stock.noler.com/us/stock/response-biomedical-corp/commitments-and-contingencies https://stock.noler.com/us/stock/response-biomedical-corp/common-stock-value https://stock.noler.com/us/stock/response-biomedical-corp/contracts-revenue https://stock.noler.com/us/stock/response-biomedical-corp/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/response-biomedical-corp/cost-of-goods-sold https://stock.noler.com/us/stock/response-biomedical-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/response-biomedical-corp/current-assets https://stock.noler.com/us/stock/response-biomedical-corp/current-liabilities https://stock.noler.com/us/stock/response-biomedical-corp/current-portion-of-long-term-debt https://stock.noler.com/us/stock/response-biomedical-corp/debt-carrying-amount https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-after-year-five https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-in-year-five https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-in-year-four https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-in-year-three https://stock.noler.com/us/stock/response-biomedical-corp/debt-maturing-in-year-two https://stock.noler.com/us/stock/response-biomedical-corp/debt-repaid https://stock.noler.com/us/stock/response-biomedical-corp/deferred-compensation-cashbased-arrangements-liability-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/deferred-finance-costs-current-net https://stock.noler.com/us/stock/response-biomedical-corp/deferred-finance-costs-gross https://stock.noler.com/us/stock/response-biomedical-corp/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/response-biomedical-corp/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-adjustment https://stock.noler.com/us/stock/response-biomedical-corp/deferred-revenue https://stock.noler.com/us/stock/response-biomedical-corp/deferred-revenue-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/response-biomedical-corp/deferred-tax-liability-not-recognized-cumulative-amount-of-temporary-difference https://stock.noler.com/us/stock/response-biomedical-corp/depreciation https://stock.noler.com/us/stock/response-biomedical-corp/depreciation-and-amortization https://stock.noler.com/us/stock/response-biomedical-corp/derivative-liabilities-current https://stock.noler.com/us/stock/response-biomedical-corp/diluted-shares https://stock.noler.com/us/stock/response-biomedical-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/response-biomedical-corp/effective-tax-rate https://stock.noler.com/us/stock/response-biomedical-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/response-biomedical-corp/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/entity-wide-revenue-major-customer-amount https://stock.noler.com/us/stock/response-biomedical-corp/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/response-biomedical-corp/eps https://stock.noler.com/us/stock/response-biomedical-corp/eps-basic https://stock.noler.com/us/stock/response-biomedical-corp/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/response-biomedical-corp/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/response-biomedical-corp/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/response-biomedical-corp/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/response-biomedical-corp/financing-cash-flow https://stock.noler.com/us/stock/response-biomedical-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/response-biomedical-corp/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/response-biomedical-corp/form-d-corporate-securities https://stock.noler.com/us/stock/response-biomedical-corp/form-d-other https://stock.noler.com/us/stock/response-biomedical-corp/general-and-administrative-expense https://stock.noler.com/us/stock/response-biomedical-corp/gross-profit https://stock.noler.com/us/stock/response-biomedical-corp/income-tax https://stock.noler.com/us/stock/response-biomedical-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/response-biomedical-corp/income-tax-expense-benefit https://stock.noler.com/us/stock/response-biomedical-corp/income-taxes-paid https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/response-biomedical-corp/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/response-biomedical-corp/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/response-biomedical-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/response-biomedical-corp/insider-transactions-stock-units https://stock.noler.com/us/stock/response-biomedical-corp/insider-transactions-warrants https://stock.noler.com/us/stock/response-biomedical-corp/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/response-biomedical-corp/interest-expense https://stock.noler.com/us/stock/response-biomedical-corp/interest-paid https://stock.noler.com/us/stock/response-biomedical-corp/inventory https://stock.noler.com/us/stock/response-biomedical-corp/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/response-biomedical-corp/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/response-biomedical-corp/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/response-biomedical-corp/inventory-write-down https://stock.noler.com/us/stock/response-biomedical-corp/investing-cash-flow https://stock.noler.com/us/stock/response-biomedical-corp/investment-income-interest https://stock.noler.com/us/stock/response-biomedical-corp/investment-warrants-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/lease-incentive-payable-current https://stock.noler.com/us/stock/response-biomedical-corp/lease-incentive-payable-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/long-term-debt https://stock.noler.com/us/stock/response-biomedical-corp/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/response-biomedical-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/response-biomedical-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/response-biomedical-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/response-biomedical-corp/net-change-in-cash https://stock.noler.com/us/stock/response-biomedical-corp/net-income https://stock.noler.com/us/stock/response-biomedical-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/response-biomedical-corp/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/response-biomedical-corp/number-of-operating-segments https://stock.noler.com/us/stock/response-biomedical-corp/operating-cash-flow https://stock.noler.com/us/stock/response-biomedical-corp/operating-expenses https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/response-biomedical-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/response-biomedical-corp/operating-leases-rent-expense-net https://stock.noler.com/us/stock/response-biomedical-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/response-biomedical-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/response-biomedical-corp/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/other-depreciation-and-amortization https://stock.noler.com/us/stock/response-biomedical-corp/other-income https://stock.noler.com/us/stock/response-biomedical-corp/other-long-term-debt-current https://stock.noler.com/us/stock/response-biomedical-corp/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/other-noncash-income https://stock.noler.com/us/stock/response-biomedical-corp/other-noncash-income-expense https://stock.noler.com/us/stock/response-biomedical-corp/other-nonoperating-expense https://stock.noler.com/us/stock/response-biomedical-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/response-biomedical-corp/other-operating-income-expense-net https://stock.noler.com/us/stock/response-biomedical-corp/other-receivables-net-current https://stock.noler.com/us/stock/response-biomedical-corp/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/response-biomedical-corp/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/response-biomedical-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/response-biomedical-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/response-biomedical-corp/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/response-biomedical-corp/payments-of-derivative-issuance-costs https://stock.noler.com/us/stock/response-biomedical-corp/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/response-biomedical-corp/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/response-biomedical-corp/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/response-biomedical-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/response-biomedical-corp/prepaid-expense-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/response-biomedical-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/response-biomedical-corp/professional-fees https://stock.noler.com/us/stock/response-biomedical-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/response-biomedical-corp/property-plant-equipment https://stock.noler.com/us/stock/response-biomedical-corp/public-float https://stock.noler.com/us/stock/response-biomedical-corp/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-after-fifth-year https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-in-fifth-year https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/response-biomedical-corp/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/response-biomedical-corp/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/response-biomedical-corp/repayments-of-secured-debt https://stock.noler.com/us/stock/response-biomedical-corp/research-and-development https://stock.noler.com/us/stock/response-biomedical-corp/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/response-biomedical-corp/restricted-stock-expense https://stock.noler.com/us/stock/response-biomedical-corp/retained-earnings https://stock.noler.com/us/stock/response-biomedical-corp/revenue https://stock.noler.com/us/stock/response-biomedical-corp/royalty-expense https://stock.noler.com/us/stock/response-biomedical-corp/royalty-guarantees-commitments-amount https://stock.noler.com/us/stock/response-biomedical-corp/sale-of-stock-price-per-share https://stock.noler.com/us/stock/response-biomedical-corp/sales-revenue-goods-gross https://stock.noler.com/us/stock/response-biomedical-corp/sales-revenue-goods-net https://stock.noler.com/us/stock/response-biomedical-corp/sales-revenue-services-net https://stock.noler.com/us/stock/response-biomedical-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/response-biomedical-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-10-k https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-10-q https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-15-12g https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-20-f https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-20fr12g https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-40-f https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-6-k https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-8-k https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-ars https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-ct-order https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-def-14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-defa14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-defm14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-f-x https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-pre-14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-prem14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-prer14a https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-regdex https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-sc-13e3 https://stock.noler.com/us/stock/response-biomedical-corp/sec-filings-sd https://stock.noler.com/us/stock/response-biomedical-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/response-biomedical-corp/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/response-biomedical-corp/selling-and-marketing-expense https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/response-biomedical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/response-biomedical-corp/share-price https://stock.noler.com/us/stock/response-biomedical-corp/shareholders-equity https://stock.noler.com/us/stock/response-biomedical-corp/shares-issued https://stock.noler.com/us/stock/response-biomedical-corp/shares-issued-shares-new-issues https://stock.noler.com/us/stock/response-biomedical-corp/short-term-debt https://stock.noler.com/us/stock/response-biomedical-corp/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/response-biomedical-corp/stock-based-compensation https://stock.noler.com/us/stock/response-biomedical-corp/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/response-biomedical-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/response-biomedical-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/response-biomedical-corp/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/response-biomedical-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-exercisable-number https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-expirations-in-period https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/response-biomedical-corp/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/response-biomedical-corp/subsequent-event-amount https://stock.noler.com/us/stock/response-biomedical-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/response-biomedical-corp/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/response-biomedical-corp/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/response-biomedical-corp/tax-reconciliation-tax-settlements-foreign https://stock.noler.com/us/stock/response-biomedical-corp/total-assets https://stock.noler.com/us/stock/response-biomedical-corp/total-liabilities https://stock.noler.com/us/stock/response-biomedical-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/response-biomedical-corp/total-long-term-debt https://stock.noler.com/us/stock/response-biomedical-corp/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/response-biomedical-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/response-biomedical-corp/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/response-biomedical-corp/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/response-biomedical-corp/utb-resulting-in-net-operating-loss-carryforward https://stock.noler.com/us/stock/response-biomedical-corp/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/response-biomedical-corp/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/response-biomedical-corp/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/response-biomedical-corp/weighted-average-number-of-shares-issued-basic